PanGen Biotech Inc (222110) — Cash Flow Quality Index
PanGen Biotech Inc (222110) has a Cash Flow Quality Index of -6.88x as of September 2025. Operating cash flow of ₩-3.66 Billion is below net income of ₩531.94 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 222110 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PanGen Biotech Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for PanGen Biotech Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PanGen Biotech Inc (222110) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for PanGen Biotech Inc (2024–2024)
Year-by-year earnings quality comparison for PanGen Biotech Inc. For live market cap and the full company financial profile, see market value of PanGen Biotech Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.17x | ₩2.99 Billion | ₩943.69 Million | — |